๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of misoprostol for the termination of second trimester pregnancies

โœ Scribed by A. Elsheikh; A. Antsaklis; S. Mesogitis; N. Papantoniou; A. Rodolakis; E. Vogas; S. Michalas

Publisher
Springer
Year
2001
Tongue
English
Weight
23 KB
Volume
265
Category
Article
ISSN
0003-9128

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Efficacy of intravaginal misoprostol in
Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: A randomized controlled trial
โœ Jan E. Dickinson,; Maryellen Godfrey; Sharon F. Evans ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 64 KB

A prospective randomized, double-blind, controlled clinical trial to compare the clinical efficacy and side effects of intravaginal misoprostol with the traditional prostaglandin, gemeprost, in second-trimester pregnancy interruption was conducted. A sample size of 100 women was calculated to demons

Vaginal misoprostol vs. concentrated oxy
Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination
โœ John Owen; John C. Hauth ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 46 KB

## Objective: To examine the efficacy of vaginal misoprostol for mid-trimester pregnancy termination. ## Methods: This randomized trial compared misoprostol, 200 microg per vaginum q 12 h to a protocol of concentrated oxytocin plus low-dose vaginal prostaglandin e2 suppositories (10 mg q 6 h). su